This is the authors' abstract. We don't add key points for this paper.
The interaction between the lactate receptor GPR81 (also known as hydroxycarboxylic acid receptor 1, or HCAR1) and Splicing Factor Proline- and Glutamine-Rich protein promotes the tumor cell malignancy. GPR81 nuclear translocation plays an important role in driving cancer progression and could serve as a potential therapeutic target. Yang et al concluded in their study that lactate and its receptor, GPR81, play crucial roles in cancer progression, and are key players in linking the lactate-rich tumor microenvironment to cancer cell behavior. The ability of nuclear GPR81 to directly regulate gene expression, combined with extracellular matrix -mediated mechanical signaling, creates a potentially robust system for the coordinated adaptation and survival of cancer cells. Understanding these interactions could lead to the discovery of new therapeutic targets and improved treatment strategies for cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Klabukov et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: